Bayer CropScience Q4 net profit up 13% amid steady revenue growth; declares ₹60 dividend

Agrochemicals major Bayer CropScience Ltd on Tuesday (May 26) reported a 13.1% year-on-year rise in net profit at ₹162 crore for the fourth quarter, compared with ₹143 crore in the same period last year.

Profit before tax for the quarter stood at ₹206.4 crore, as against ₹167.9 crore in the corresponding quarter last year.

Revenue grew 5.2% year-on-year to ₹1,100.8 crore from ₹1,046.4 crore, while EBITDA increased 18.8% to ₹202.9 crore from ₹170.8 crore. EBITDA margin stood at 18.4% versus 16.3% in the corresponding quarter last year.

Also Read: DCM Shriram, Bayer CropScience to collaborate on sustainable agri solutions

Bayer CropScience reported revenue from operations of ₹5,675 crore in FY 2025-26, compared with ₹5,473.4 crore in the previous year. Profit before tax stood at ₹854.9 crore, against ₹707.4 crore in the corresponding period last year

Simon Wiebusch, Vice Chairman and Managing Director and CEO of BCSL, said, “In Q4, we delivered a resilient performance, with revenue growing ~5%, reflecting the underlying strength of our business in a challenging environment, even as growth moderated versus our ambitions. While corn saw a softer season, our diversified portfolio sustained momentum.

Our full-year performance remained measured, shaped by Kharif disruptions and a deliberate focus on disciplined channel management and long-term value creation over short-term volume acceleration. We remain well-positioned to drive sustainable, quality-led growth going forward."

Also Read: Bayer CEO bets on India as a top market by 2030: 'Not a back office but an innovation hub'

The company’s board of directors, at its meeting held on May 26, 2026, approved the audited financial results for the financial year ended March 31, 2026.

The board also recommended a final dividend of ₹60 per share for FY26, subject to approval by shareholders at the forthcoming Annual General Meeting.

Speaking on the FY results, Vinit Jindal, Executive Director and Chief Financial Officer, BCSL, said, "Profit After Tax grew by 21% for the full year. Amidst external challenges, the Company maintained financial stability through disciplined cost and cash flow management.

The balance sheet remains strong, providing flexibility to support operations and strategic priorities. We continue to focus on driving profitable growth and maintaining balance-sheet resilience."

Also Read: Bayer aims to make India a top market by 2030, says CEO Bill Anderson

Shares of Bayer CropScience Ltd ended at ₹4,511.95, up by ₹138.50, or 3.17%, on the BSE.